Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for VTRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1987. Start Trial.
Date Value
December 31, 2025 2.316B
December 31, 2024 2.303B
December 31, 2023 2.800B
December 31, 2022 2.953B
December 31, 2021 3.017B
December 31, 2020 1.232B
December 31, 2019 1.804B
December 31, 2018 2.342B
December 31, 2017 2.065B
December 31, 2016 2.047B
December 31, 2015 2.008B
December 31, 2014 1.015B
December 31, 2013 1.107B
December 31, 2012 949.02M
December 31, 2011 720.42M
December 31, 2010 931.40M
December 31, 2009 605.08M
December 31, 2008 384.45M
December 31, 2007 167.69M
March 31, 2007
Date Value
March 31, 2006 416.56M
March 31, 2005 203.71M
March 31, 2004 225.58M
March 31, 2003 313.14M
March 31, 2002 346.47M
March 31, 2001 67.02M
March 31, 2000 119.22M
March 31, 1999 163.45M
March 31, 1998 52.65M
March 31, 1997 46.54M
March 31, 1996 75.57M
March 31, 1995 136.53M
March 31, 1994 35.63M
March 31, 1993 68.34M
March 31, 1992 45.35M
March 31, 1991 39.26M
March 31, 1990 19.02M
March 31, 1989 17.14M
March 31, 1988 24.15M
March 31, 1987 23.13M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Pfizer Inc. 11.70B
Eli Lilly & Co. 16.81B
Merck & Co., Inc. 16.47B
Bristol Myers Squibb Co. 14.16B
Johnson & Johnson 24.53B